| Bryan Y Wong, MD PHD | |
|
2946 E Banner Gateway Dr, Gilbert, AZ 85234 | |
| (480) 256-6444 | |
| (480) 256-4607 |
| Full Name | Bryan Y Wong |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 26 Years |
| Location | 2946 E Banner Gateway Dr, Gilbert, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841291929 | NPI | - | NPPES |
| P00732871 | Other | AZ | RAILROAD MEDICARE |
| 406300 | Medicaid | AZ |
| Facility Name | Location | Facility Type |
|---|---|---|
| Banner Gateway Medical Center | Gilbert, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Banner Cancer Center Specialists Llc | 6103097779 | 266 |
News Archive
The Norwegian biopharmaceutical company Lytix Biopharma and Korean company KAEL-GemVax today announced approval by the Norwegian Medicines Agency ('Statens Legemiddelverk') to test a combination of LTX-315 and GV1001 as vaccine therapy in patients with resected tumours. Lytix Biopharma CEO Gunnar Salid states, "We are delighted to announce the approval of our joint study to test a combination of two very interesting experimental drugs.
Scientists from the University of Maryland and Beijing Normal University are partnering to track and predict the impact of climate change internationally.
Apoptosis is a form of "cell suicide", where a cell self-terminates, ideally as planned or programmed, enabling multi-cellular organisms to continue to live, develop and thrive.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a second Phase 1B clinical safety and pilot efficacy study with PMX-60056, a small synthetic molecule designed to reverse heparin and low molecular weight heparin anticoagulants.
› Verified 3 days ago
| Entity Name | Banner Cancer Center Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518253152 PECOS PAC ID: 6103097779 Enrollment ID: O20110913000224 |
News Archive
The Norwegian biopharmaceutical company Lytix Biopharma and Korean company KAEL-GemVax today announced approval by the Norwegian Medicines Agency ('Statens Legemiddelverk') to test a combination of LTX-315 and GV1001 as vaccine therapy in patients with resected tumours. Lytix Biopharma CEO Gunnar Salid states, "We are delighted to announce the approval of our joint study to test a combination of two very interesting experimental drugs.
Scientists from the University of Maryland and Beijing Normal University are partnering to track and predict the impact of climate change internationally.
Apoptosis is a form of "cell suicide", where a cell self-terminates, ideally as planned or programmed, enabling multi-cellular organisms to continue to live, develop and thrive.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a second Phase 1B clinical safety and pilot efficacy study with PMX-60056, a small synthetic molecule designed to reverse heparin and low molecular weight heparin anticoagulants.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bryan Y Wong, MD PHD 2940 E Banner Gateway Dr, Suite 450, Gilbert, AZ 85234-2168 Ph: (480) 265-6444 | Bryan Y Wong, MD PHD 2946 E Banner Gateway Dr, Gilbert, AZ 85234 Ph: (480) 256-6444 |
News Archive
The Norwegian biopharmaceutical company Lytix Biopharma and Korean company KAEL-GemVax today announced approval by the Norwegian Medicines Agency ('Statens Legemiddelverk') to test a combination of LTX-315 and GV1001 as vaccine therapy in patients with resected tumours. Lytix Biopharma CEO Gunnar Salid states, "We are delighted to announce the approval of our joint study to test a combination of two very interesting experimental drugs.
Scientists from the University of Maryland and Beijing Normal University are partnering to track and predict the impact of climate change internationally.
Apoptosis is a form of "cell suicide", where a cell self-terminates, ideally as planned or programmed, enabling multi-cellular organisms to continue to live, develop and thrive.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a second Phase 1B clinical safety and pilot efficacy study with PMX-60056, a small synthetic molecule designed to reverse heparin and low molecular weight heparin anticoagulants.
› Verified 3 days ago
Sandhyaben P Patel, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1900 N Higley Rd, Gilbert, AZ 85234 Phone: 480-543-2134 Fax: 480-512-6089 | |
Dr. Shivakumar Vignesh, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2946 E Banner Gateway Dr., Suite 400, Gilbert, AZ 85234 Phone: 480-256-3332 Fax: 813-449-8028 | |
Dr. Noreen Catherine Ruane, D.O. Internal Medicine Medicare: Medicare Enrolled Practice Location: 3555 S Val Vista Dr, Gilbert, AZ 85297 Phone: 602-933-0777 Fax: 602-933-0755 | |
Dr. Ala Eddin Samir Sagar, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2940 E Banner Gateway Drive, Gilbert, AZ 85234 Phone: 480-256-6444 Fax: 480-256-3682 | |
Theresa Ong Liu Dumlao, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2946 E Banner Gateway Dr, Suite 450, Gilbert, AZ 85234 Phone: 480-256-6444 Fax: 480-256-4683 | |
Dr. Zachary Phillip Yeung, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2946 E Banner Gateway Dr, Gilbert, AZ 85234 Phone: 480-245-6444 Fax: 480-256-4623 | |
Richard D Sue, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2946 E Banner Gateway Dr, Gilbert, AZ 85234 Phone: 480-256-6444 Fax: 480-256-3682 |